This round is no longer accepting investments, but others just like it are live now.

CLOSED

GET A PIECE OF XRHEALTH

On-demand virtual care reinvented

XRHealth virtual clinics combine immersive VR/AR technology with telehealth to help patients mitigate the symptoms of their chronic conditions in the comfort of their home via the metaverse.

This Reg CF offering is made available through StartEngine Capital, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Company Image

$255,146.53 Raised

TEAM

Hillel Bachrach

Hillel Bachrach • Board of Directors

Entrepreneur with more than 40 years of experience managing and funding the commercial global introduction of innovative and revolutionary medical and life science technologies. After a successful career as an entrepreneur starting many companies that were either sold or went public, in 2005 Hillel founded 20/20 HealthCare Partners, an investment company where he is the Managing Partner.

Read More

Eran Orr

Eran Orr • CEO, Founder & Director

During a 15-year career as an F-16 fighter pilot in the Israeli Air Force and several executive positions, Eran has established himself as a worldwide leader in the XR and health industries and is an official Forbes Councils Member.

Read More

Gilad Meiri

Gilad Meiri • Board of Directors

Gilad is a serial entrepreneur and active angel investor. He currently acts as a board member and the CFO of Cupixel. Before that Gilad founded and was the CEO of Neura (acquired by Otonomo Technologies) and Spicebox Labs. Gilad is also a director in publicly traded Third Eye Systems (TASE: THES).

Read More

Reasons to Invest

  • The metaverse global market opportunity is projected to reach 800 billion by 2024 and the fast-growth telehealth market is predicted to reach a value of $70.19 billion by 2026XRHealth has already contributed significantly to this projection. In 2021, XRHealth generated over $1M of this revenue in YTD and our QoQ growth has been 300+%.
  • XRHealth was operating clinics in the metaverse before there was a common word to describe the next evolution of the internet or web 3.0. To date, XRHealth has treated over 2,000 patients in 5 virtual clinics. XRHealth plans to be a central player in DTx technology (aka Digital Therapeutics) using virtual and augmented reality to offer therapy in the metaverse.
  • XRHealth is poised to be an industry leader in VR/AR therapy due to strict adherence to FDA and HIPPA regulations during the past 5 years. XRHealth currently has 3 approved patents, 8 FDA registered medical applications, and 6 3rd party apps already in use. The digital services are covered by insurance thanks to changes in CPT codes during the pandemic, making it one of the most trustworthy digital health services.

Overview


Bringing Patient Care Into the Metaverse

XRHealth is spearheading the VR/AR therapy revolution by combining proprietary FDA-registered medical virtual reality (VR/AR) therapy with conventional telehealth solutions to offer patients personalized care they need for chronic conditions in the metaverse.

1:1 Virtual Therapy With Virtual Reality

From the Comfort of Home



A comprehensive therapeutic at-home care solution for multiple chronic conditions:


Our Virtual Therapy is Safe, Secure and Loved by Our Patients:



We also offer Software as a Service (Saas) to providers, hospitals, and rehabilitation centers.

Our Story




XRHealth was founded by Eran Orr, an Air Force veteran pilot and an industry early adopter of virtual reality (VR). After suffering from chronic neck pain caused by heavy helmets used during flights, he saw a need to bring his VR expertise into healthcare. Based on his experience, he believed VR was the perfect tool for simulated training to maximize the effectiveness of physical therapy.


So...he set on a new mission to help others recover from pain by using VR. He teamed up with interdisciplinary experts including medical professionals, data scientists, graphic artists, and more to make it happen. XRHealth became the first company to combine a telehealth online clinic with gamified virtual reality facilitated by licensed therapists.

The Problem


Current Telehealth Technology Provides Limited Treatment

1. Chronic conditions affect 60% of Americans, with more than 40% experiencing 2 or more conditions. Some conditions may require long waits to receive care to heavy patient loads in clinics.


2. Despite the need for ongoing care, patients are often over-taxed due to 'commuter fatigue,' pain of care, or boredom. As a result, patients have a 50% average treatment adherence rate and 70% churn rate (in comparison with 91.2% adherence and 10% churn with XRHealth).


3. Digital at-home services became the 'new normal,' which highlighted the gaps in brick and mortar care including the lack of data, real-time progress insights, easy-to-use platforms and interfaces, access to clinicians outside of therapy, and more.


Source 1Source 2, Source 3

THE Market


A Fast Growing Industry With Impact Across Healthcare Verticals 

The fast-growth telehealth market is projected to grow to $70.19 billion by 2026 and the metaverse global market is expected to climb to 800 billion by 2024. Telehealth services doubled during the pandemic and is expected to be the 'new normal' as lifestyles adjust and digital services improve.


The pandemic doubled the number of people who have used telehealth from 39.4% pre-COVID-19 to 79.5% post-quarantine. 



Our services meet the specific needs of the following patient markets:



Our services meet the specific needs of the following patient markets: 



The Solution


Building Therapy in the Metaverse

  • Our platform combines immersive VR/AR technology with telehealth services, licensed clinicians, and advanced data analytics for an all-in-one innovative solution for patients to receive high-quality care in the comfort of their homes via the Metaverse (the new term used to describe the virtual world).
  • We provide our patients with enjoyable treatments that feel like less work and more fun. Patients participate in weekly sessions with a licensed therapist who guides and monitors their treatment in real-time and adjusts therapy protocols remotely in the VR/AR headset.
  • In between sessions, the patient practices virtual reality exercises according to the tailored VR digital treatment plan (in addition to conventional exercises that may be suggested).
  • Patients use our mobile app to track their own progress, chat with their therapist, and communicate easily with clinic staff.
  • After each therapy session, the patient's insurance company is billed for telehealth services and Remote Therapeutic Monitoring (RTM) (a newly introduced CPT code now used to support the growth of digital therapeutics and foster the development of remote patient services).




Virtual Worlds, Real Results

Patients enjoy therapeutic exercises that feel more like games than work to promote adherence to treatment. Patients and therapists gain instant progress insights from biofeedback and other data-tracking mechanisms that flows from the headset to the XRHealth platform. Therapists can use this data to personalize treatments for optimal success.





XRHealth takes digital health services to the web 3.0 revolution in the metaverse 


In the old world, you needed to drive to a clinic or hospital and go to a specific room to meet with a therapist who is often chosen by the clinical setting or HMO plan. But the way we are conducting therapy is rapidly changing to match the modern lifestyle.


In the metaverse, you can enter any virtual treatment room and meet any therapist you want (or meet other patients) no matter where they are. And we believe this fosters better compliance with treatment, which we are already seeing from primary surveys.


That's why we are building some of the first virtual clinics in the metaverse. 

This is the new world:

  1. Quantified data
  2. Real-time progress analysis
  3. Accessibility to care
  4. Improved patient experience


Gamified therapy fosters better treatment compliance because its fun! 





Better Results = Better Quality of Life 

XRHealth patients across multiple health verticals report a decrease in symptoms related to chronic pain, stress & anxiety, and neurological conditions.


Pain Management vertical:



Behavioral Health vertical:



Neurological Disorders vertical:


Business Model


Our GO TO MARKET Strategy Combines:



B2C: Direct to Consumer



Our Insurance Coverage



B2B: SaaS - Virtual Treatment Rooms

In our B2B model, inpatient and outpatient facilities partner with XRHealth to expand their skilled therapy and rehabilitation services. We generate revenue throughout the process. 




Our Partner Providers


The Patient's Voice




"It's better to have 100 users love you than 1 million [sic] kinda like you. The true seed of scale is love, and you can't buy it, hack it, or game it", said Sam Altman, Master of scale.


Our Growth


Growth on all fronts 


The XRhealth platform expansion drives growth! To date, XRHealth has treated over 2,000 patients in 5 operating virtual clinics. 


Therapy in the metaverse is no longer a dream or science fiction. It's already working, making it clear that the new reality of healthcare is in immersive, digital applications.


Let's take a look at the numbers. XR Health is expanding exponentially to meet the growing demand, with a current growth rate of 400%.


*The above graphic includes unaudited financial information and is subject to change. From Q1-Q3 2021, the Company has achieved $1.1M in revenue. The Company is pending their final Q4 unaudited data. Please refer to the risk factors in our Form C regarding forward looking information and our financial information.



Future Growth Plan

The use of funds is focused on

(1) Clinic expansion

(2) RnD - platform expansion


Insert Image
Drop image
(or click)

Loading image

ABOUT

HEADQUARTERS
1330 Beacon St STE 209
Brookline, MA 02446
WEBSITE
View Site
XRHealth virtual clinics combine immersive VR/AR technology with telehealth to help patients mitigate the symptoms of their chronic conditions in the comfort of their home via the metaverse.

TERMS

XRHealth
Overview
PRICE PER SHARE
$25.63
DEADLINE
Feb. 9, 2022 at 7:59 AM UTC
VALUATION
$80.97M
FUNDING GOAL
$10K - $1.07M
Breakdown
MIN INVESTMENT
$256.30
MAX INVESTMENT
$106,979.62
MIN NUMBER OF SHARES OFFERED
390
MAX NUMBER OF SHARES OFFERED
41,746
OFFERING TYPE
Equity
SHARES OFFERED
Common Stock

Maximum Number of Shares Offered subject to adjustment for bonus shares

Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*

Early Bird

Early Bird Bonus - First 7 days | XRHealth t-shirt

Volume

Tier 1 perk ($256) - Limited edition merchandise for investors only: XRHealth T-shirt)

Tier 2 perk ($512) - Limited edition merchandise for investors only: XRHealth signature coin)

Tier 3 perk ($1,500) - Limited edition merchandise for investors only: XRHealth stress ball + signature coin + T-shirt)

Tier 4 perk ($3,000) - Exclusive webinar with Eran Orr, XRHealth CEO, "Overview about Healthcare and XR") 

Tier 5 perk ($5,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps)

Tier 6 perk ($10,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps + 1:1 meeting with Eran Orr, XRHealth CEO, on Zoom) 

*All perks occur when the offering is completed.

Irregular Use of Proceeds

We will not incur any irregular use of proceeds.

PRESS

Article Image
VR Focus

VRHealth To Make Its Medical Platform Available For Use At Home

Article Image
Times Magazine

The Coronavirus Outbreak Could Finally Make Telemedicine Mainstream in the U.S.

Article Image
Rachel Ray Show

Medical Virtual Reality featured on the Rachael Ray Show.

Article Image
MobiHealth News

VRHealth, AARP launch VR platform for remote patient monitoring, in-home therapy

Article Image
CNET

VRHealth works with Oculus to bring you at-home exercises using virtual reality

ALL UPDATES

02.06.22

48 Hours Left to Invest! Don't miss this opportunity to change the face of healthcare.

Let's face it. Our world is changing right before our eyes as technology advances. And this is a big deal to healthcare. Now, we are on the brink of a massive healthcare revolution. The impending model is more:

  • Personalized
  • Digital
  • Interactive
  • Data-centric
  • Convenient
  • and most of all, fun. 

What would you like to add to the list?  

We welcome you to not just have a seat at the table, but to have a voice at it too! You have 48 hours left to invest in the future of healthcare. Don't miss out!

02.01.22

One week left! Don't miss out on the opportunity of a lifetime.


The campaign is winding down. And we'd hate to see you miss out. If you've been following the tech or healthcare news, healthcare is changing thanks to budding new technology and the improvements of existing tech. If you want to be part of making big waves in healthcare, now's your chance!

Invest in the next big thing in healthtech. Invest in the metaverse.

01.31.22

We're in Nasdaq!

We might be biased, but the market isn't. See what the big players are saying about us in Nasdaq.

01.19.22

We've been featured in Tech Crunch!

[Image: LG Nova]


Nothing quite makes it all feel real like seeing XRHealth in Tech Crunch!


Read how we've been shortlisted for LG Nova's incubator here!

01.18.22

The Consumer Electronics Show (CES) was a hit!

We started this year with a bang! XRHealth took our proof-of-concept to Las Vegas at one of the most noteworthy electronics trade shows in the world.

Check out our pics from the show, where we revealed our proof-of-concept for our LG Nova proto challenge contest (which we won). Treatment rooms in the metaverse in assisted living and continuing care retirement communities are on their way!


Nothing kicks off the day quite like a mimosa. 


Eran Orr with a captive audience


Eran test-driving our booth.


It's a game. It's therapy. It's a treatment room in the metaverse. 




01.13.22

The 30 Day Countdown Has Begun

Thanks for supporting XRHealth on our amazing journey. The last 30 days of our first crowdfunding campaign is winding down on Start Engine.

We wanted to make sure you don't miss out on this incredible opportunity to be part of building the future of healthcare.

We have been working diligently to address chronic conditions via VR/AR technology for the past two years and now we are ready to scale up. And with your contribution, we can help millions of people thrive despite their chronic conditions.

It's been an amazing crowdfunding journey. And now this round is coming to an end. 

At the time of writing this post, we’ve already raised over $200K on this round alone. On top of this, we've developed new partnerships that are bound to send us into the new year with an extra boost. And there is still room for you!

Are you ready to join in the mission to take these achievements one step further as we spread nationally and globally?

01.12.22

Just a little chat with one of the world's biggest players in extended reality

If you're not excited about VR/AR in the Metaverse yet, listen to our founder and CEO, Eran Orr, speak about our therapeutic applications with HTC VIVE. And check out exciting visuals! Who knew this would be the future of treatment. 


01.06.22

Introducing XRHealth Treatment Rooms with HTC’s VIVE Focus 3 and VIVE Flow


XRHealth has just teamed up with HTC, the global leader in premium virtual reality (VR). HTC is paving the way for businesses to use VR technology. With our partnership, this now means they can step up their game with treatment rooms in the Metaverse.

Clinicians will be able to use VIVE Focus 3, preloaded with XRHealth’s applications, to create a virtual treatment center that will engage and treat patients remotely.

VIVE Focus 3 will help amp up the therapy with high-quality visuals, a replaceable long-lasting battery, and an ultra-wide 120-degree field of view. Now, it’ll be even easier to feel part of the virtual world.

Patients can also enter their virtual treatment rooms from the comfort of their homes (or anywhere they have internet) using the ultra-lightweight VIVE Flow accessible with an Android 5G smartphone! And feel like they are transported to other worlds with their "VR colored" sunglasses, making VR feel more accessible to those just stepping into the Metaverse. 

With options like this, patients are bound to feel motivated to complete their exercises. Because who wouldn’t want to chase dragons or sit by the virtual seaside instead of doing the same old, boring routines?

01.04.22

XRHealth and LG Nova have teamed up to pilot treatment rooms in the metaverse in assisted living and continuing care retirement communities


It's a great honor to announce that we're among a handful of socially impactful startups accepted into LG NOVA’s Proto Challenge, their preliminary startup competition designed to coincide with LG NOVA’s global challenge program, Mission for the Future, to find technological solutions that will contribute to a better life. LG is allocating more than $1 million in initial funding to selected winning companies from LG NOVA Proto Challenge.

 

As part of the program, we will be piloting virtual treatment rooms in assisted living and continuing care retirement facilities to foster quality remote care using our VR/AR technology. We will be showcasing our proof-of-concept at the Consumer Electronics Show (CES) in Las Vegas on January 5-7, 2022. 


“What better forum than CES – the most influential tech event in the world – to celebrate the startups and entrepreneur communities building solutions to some of the world’s most pressing issues,” said LG NOVA Head Dr. Sokwoo Rhee, Corporate Senior Vice President for Innovation at LG Electronics. “As our LG NOVA program progresses, we’re using the power of collaboration to fuel innovation for society overall.”



What a way to kick-off the new year! Wishing all of you a meaningful, healthy year and years to come. 

12.28.21

The Metaverse Won Christmas!

If you're wondering what tech trends to follow, you can always get a glimpse of what tops the charts after Christmas. Well, this year, CNBC writer, Steve Koach, revealed that the Oculus VR app was the most popular app in Apple's App Store on Christmas Day.  For those of you not following 'techie' news, Meta (Facebook), acquired Oculus back in 2014, anticipating the next big tech boom with virtual reality. Fast-forward to the present and they are proving themselves seers in the Web 3.0 revolution. 

According to Koach, the app topping the charts indicates that Oculus VR headsets were among the most popular gifts this year. Because why would you download an app without the headset, right? This is also a sign of this year's tech trends. This may be the first year that Meta's Oculus app lead the way, but it is indubitably the last. 

Oculus might not stay at the top, but this chart supports the theory that the public is getting ready to adopt metaverse technology.

Are you ready to step into the Metaverse? Or help build it? 


REWARDS

Multiple investments in an offering cannot be combined to qualify for a larger campaign reward.

$256

Tier 1 perk

($256) - Limited edition merchandise for investors only: XRHealth T-shirt)

$512

Tier 2 perk

($512) - Limited edition merchandise for investors only: XRHealth signature coin)

$1,500

Tier 3 perk

($1,500) - Limited edition merchandise for investors only: XRHealth stress ball + signature coin + T-shirt)

$3,000

Tier 4 perk

($3,000) - Exclusive webinar with Eran Orr, XRHealth CEO, "Overview about Healthcare and XR")

$5,000

Tier 5 perk

($5,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps)

$10,000

Tier 6 perk

($10,000) - XRHealth VR headset loaded with a lifetime subscription to all our VR therapy apps + 1:1 meeting with Eran Orr, XRHealth CEO, on Zoom)

JOIN THE DISCUSSION

0/2500

PINNED BY STARTUP

CN
Calvin Nguyen

4 years ago

What's your monthly burn? When do you anticipate rapid-growth from user adoption? VR is still new is "metaverse" is still in its infancy contrary to what the news make people believe (still 5 years out at a minimum). VR adoption continues to grow, but only within a small niche and limited to tech savvy groups whereas I feel like this targets the general population, so how will you overcome this?

Show more

1

0

EO
Eran Orr

XRHealth

4 years ago

Thanks for you comments. Our average patients are not tech savvy people - all of them are people with chronic condition that find our services and the VR helpful ( average age 62 , take a look on the testimonials video) . The reason we opened the VR\AR clinics is that we also think VR\AR as a long way to go for market adoption so that's way we established the VR\AR clinics to solve the last mile VR\AR problem

Show more

0

PINNED BY STARTUP

SS
Scott Schwartz

4 years ago

Have you thought about integrating this with the Quest 2 or other Meta (Facebook) plans? There will be thousands of these in service.

Show more

1

0

EO
Eran Orr

XRHealth

4 years ago

Thanks for your comment. We officially partnered with Facebook a few years ago : https://medcitynews.com/2018/10/oculus-vrhealth/ Health related VR apps are complex and can't be be part of a general platform because of patient data regulations and other legal limitations. Our goal is to work with any platform\company that will provide us with the tools\legal support we need for our business

Show more

0

CK
Cho Yee Kong

3 years ago

Any Schedule for the perk delivery? Thanks.

0

0

PM
Paul Moravec

3 years ago

Hello, just curious about estimated shipping date of the VR headset with subscription that was promised to investors putting inn$5k. Thanks.

Show more

0

0

YH
Yosef Hertz

3 years ago

I am pasting my question again, still haven't gotten a response, plz reply: Hi, can you update recent revenue traction, where did Q4 revenue come in at? With the metaverse trending during Q4 I'd think there would be a strong uptick in downloads. Can you indicate if and where you've seen growth? Also, from looking at online reviews it seems there are a lot of positives but company culture has not been strong in the past. How are you improving on this, so that employees are retained and happy? A number of employees that I saw left too soon after joining. Thanks

Show more

1

0

EO
Eran Orr

XRHealth

3 years ago

Thanks Yosef for your question. We are not posting at the moment any numbers regarding Q4 because are still closing our books. I can confirm that all numbers we published on this page and in this offering are correct numbers. We are not an app that users can download , we are treating patients remotely in VR treatment rooms which we have been developing for the last 5 years. We decided to become a healthcare provider and not just a tech company about year ago, As a result we have made company restructure and that's the background for those previous employees comments you mentioned. We don't see those comments as a company culture problem. Hope that answer your concerns. Best,

Show more

0

YH
Yosef Hertz

3 years ago

Hi, can you update recent revenue traction, where did Q4 revenue come in at? With the metaverse trending during Q4 I'd think there would be a strong uptick in downloads. Can you indicate if and where you've seen growth? Also, from looking at online reviews it seems there are a lot of positives but company culture has not been strong in the past. How are you improving on this, so that employees are retained and happy? A number of employees that I saw left too soon after joining. Thanks

Show more

0

0

VP
Vin P

3 years ago

Thx for a previous response! It'll be interesting & attractive to know what XRHealth would consider it's moat. What would stop the Health giants from entering this field, as post-Covid, TeleHealth is a reality.

Show more

1

0

EO
Eran Orr

XRHealth

3 years ago

Besides 26 patents we submitted to date we believe that our data and knowledge of how to treat patients in a virtual clinics , our distribution channels, our regulation - FDA/CE a products , our partnerships and our ability to create a fully integrated platform which will replace brick and mortar clinics in the next few years. We have been working 6 years and spent $30M to date to get to our current status and we believe it will be very hard to copy those.

Show more

0

VP
Vin P

3 years ago

Hi, interesting opportunity. Appreciate input on exit strategy for a small investor. Thx.

Show more

1

1

EO
Eran Orr

XRHealth

3 years ago

Thanks for asking. We are aiming for an IPO moving forward.


0

KK
Karim Kibaa

3 years ago

That is a crazy valuation compared to your revenue, i am so in the idea but the valuation is so high.

Show more

2

0

DF
Derek Fenwick

3 years ago

Same reaction. Eran, can you please speak to how you came to this valuation? If it is already spelled out and I missed it, please point me toward it, thank you

Show more

0

kn
kymba nijuck

4 years ago

I was a patient of XR Health. They assured me on multiple occasions prior to receiving services that their services would be completely covered by my insurance, it was not. They told me that their physical therapist had experience with one of my conditions, she did not and gave me an exercise that literally was the first result that one would find on google for an exercise for that condition. Because of my negative experiences, I left a 1-star review on Google. In response, several of the top-level executives at XR Health left fraudulent/conflict of interest reviews in an attempt to bury my 1-star review. And they did so in such an inept manner as to be laughable. Of the 10 reviews currently on Google, 3 are from people with no history of making reviews and six are obviously from XR Health staff, including executives and... wait for it... their Social Marketing person! Clair Polansky - Content & Social Marketing Eran Orr - Founder & CEO Tal Arbel - VP Product Data & AI Shira Orr - Manager - Medical & Scientific Publications Kate Gleason - Clinic Director Noa Lustgarten - Director, Clinical Delivery Feel free to Google any of the above names + "XR Health". These folks are obviously not rocket scientists, have questionable ethics, and do not understand Google's Terms and Conditions. I think you can find better people to invest with.

Show more

8

0

EO
Eran Orr

XRHealth

4 years ago

Thanks for your response. We are not using Google reviews because Google is not verifying if you are a real patient or not. You are welcome to see that most patients disagree with your comments : https://www.trustpilot.com/review/xr.health Like other providers that accept insurance, the patient is responsible to pay the co pay and/or deductible after the treatment was done. We treated over 2000 patients this year alone in 3 different countries and we have NPS sckre that is 3 times better than the health care market average. I'm sorry to hear you had a bad experience and hopefully you will come back for another round so you will be able to benefit from our services like our other patients. Best,

Show more

0

HOW INVESTING WORKS

Cancel anytime before 48 hours before a rolling close or the offering end date.

FAQ Timeline

WHY STARTENGINE?

Rewards Icon
REWARDS

We want you to succeed and get the most out of your money by offering rewards and memberships!

Lock Icon
SECURE

Your info is your info. We take pride in keeping it that way!

Ellipse Icon
DIVERSE INVESTMENTS

Invest in over 200 start-ups and collectibles!

FAQS

With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.

With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.

At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.

Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.

StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.

For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.

For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.

Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.

Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.

Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.

RAISED
$255,146.53
INVESTORS
109
MIN INVEST
$256.30
VALUATION
$80.97M

Important Message

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.

www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.

Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary LLC (“SE Primary”), a broker-dealer registered with the SEC and FINRA / SIPC. You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system (ATS) regulated by the SEC and operated by SE Primary. SE Primary is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.

StartEngine facilitates three types of primary offerings:

1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.

Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice concerning any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy, or completeness of any information. Neither StartEngine nor any of its officers, directors, agents, and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site.

Investing in private company securities is not suitable for all investors. An investment in private company securities is highly speculative and involves a high degree of risk. It should only be considered a long-term investment. You must be prepared to withstand a total loss of your investment. Private company securities are also highly illiquid, and there is no guarantee that a market will develop for such securities. Each investment also carries its own specific risks, and you should complete your own independent due diligence regarding the investment. This includes obtaining additional information about the company, opinions, financial projections, and legal or other investment advice. Accordingly, investing in private company securities is appropriate only for those investors who can tolerate a high degree of risk and do not require a liquid investment. See additional general disclosures here.

By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.

Canadian Investors

Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.

California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.

StartEngine Marketplace (“SE Marketplace”) is a website operated by StartEngine Primary, LLC (“SE Primary”), a broker-dealer that is registered with the SEC and a member of FINRA and the SIPC.

StartEngine Secondary (“SE Secondary”) is our investor trading platform. SE Secondary is an SEC-registered Alternative Trading System (“ATS”) operated by SE Primary that matches orders for buyers and sellers of securities. It allows investors to trade shares purchased through Regulation A+, Regulation Crowdfunding, or Regulation D for companies who have engaged StartEngine Secure LLC as their transfer agent. The term “Rapid,” when used in relation to transactions on SE Marketplace, specifically refers to transactions that are facilitated on SE Secondary, This is because, unlike with trades on the StartEngine Bulletin Board (“SE BB”), trades on SE Secondary are executed the moment that they are matched.

StartEngine Bulletin Board (“SE BB”) is a bulletin board platform on which users can indicate to each other their interest to buy or sell shares of private companies that previously executed Reg CF or Reg A offerings not necessarily through SE Primary. As a bulletin board platform, SE BB provides a venue for investors to access information about such private company offerings and connect with potential sellers. All investment opportunities on SE BB are based on indicated interest from sellers and will need to be confirmed. Even if parties express mutual interest to enter into a trade on SE BB, a trade will not immediately result because execution is subject to additional contingencies, including among others, effecting of the transfer of the shares from the potential seller to the potential buyer by the issuer and/or transfer agent. SE BB is distinct and separate from SE Secondary. SE Secondary facilitates the trading of securities by matching orders between buyers and sellers and facilitating executions of trades on the platform. By contrast, under SE BB, SE Primary assists with the facilitation of a potential resulting trade off platform including, by among other things, approaching the issuer and other necessary parties in relation to the potential transaction. The term “Extended”, when used in relation to transactions on SE Marketplace denotes that these transactions are conducted via SE BB, and that these transactions may involve longer processing times compared to SE Secondary for the above-stated reasons.

Even if a security is qualified to be displayed on SE Marketplace, there is no guarantee an active trading market for the securities will ever develop, or if developed, be maintained. You should assume that you may not be able to liquidate your investment for some time or be able to pledge these shares as collateral.

The availability of company information does not indicate that the company has endorsed, supports, or otherwise participates with StartEngine. It also does not constitute an endorsement, solicitation or recommendation by StartEngine. StartEngine does not (1) make any recommendations or otherwise advise on the merits or advisability of a particular investment or transaction, (2) assist in the determination of the fair value of any security or investment, or (3) provide legal, tax, or transactional advisory services.